AMINOLEVULINIC ACID for Bladder transitional cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where AMINOLEVULINIC ACID was used for Bladder transitional cell carcinoma.
Most Reported Side Effects for AMINOLEVULINIC ACID
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 293 | 17.8% | 0 | 0 |
| Off label use | 178 | 10.8% | 1 | 3 |
| Wrong technique in product usage process | 173 | 10.5% | 0 | 2 |
| Erythema | 144 | 8.8% | 0 | 1 |
| Product quality issue | 132 | 8.0% | 0 | 0 |
| Poor quality product administered | 124 | 7.6% | 0 | 0 |
| Pain | 102 | 6.2% | 0 | 4 |
| Product dose omission issue | 93 | 5.7% | 0 | 0 |
| Application site pain | 90 | 5.5% | 0 | 6 |
| Application site erythema | 81 | 4.9% | 0 | 4 |
| Accidental exposure to product | 73 | 4.4% | 0 | 0 |
| Blister | 52 | 3.2% | 0 | 0 |
| Product physical issue | 48 | 2.9% | 0 | 0 |
| Oedema | 36 | 2.2% | 0 | 0 |
| Eye irritation | 35 | 2.1% | 0 | 1 |
Other Indications for AMINOLEVULINIC ACID
Product used for unknown indication (765)
Actinic keratosis (466)
Photodynamic diagnostic procedure (63)
Photodynamic therapy (55)
Acne (35)
Squamous cell carcinoma of skin (34)
Glioblastoma (23)
Glioma (10)
Skin disorder (8)
Skin cancer (7)
Other Drugs Used for Bladder transitional cell carcinoma
GEMCITABINE (335)
CISPLATIN (252)
PEMBROLIZUMAB (251)
ATEZOLIZUMAB (195)
CARBOPLATIN (146)
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (119)
AVELUMAB (104)
DURVALUMAB (88)
NIVOLUMAB (80)
ENFORTUMAB VEDOTIN-EJFV (68)